| Q33506217 | A review of quality of life instruments used in liver transplantation |
| Q44302883 | Association of CD8 T cells with depression and anxiety in patients with liver cirrhosis |
| Q36823403 | Depression and Anxiety as Risk Factors for Morbidity and Mortality After Organ Transplantation: A Systematic Review and Meta-Analysis |
| Q33645706 | Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms? |
| Q38240830 | Depression and psychosocial correlates of liver transplant candidates: a systematic review |
| Q34786778 | Depression as a risk factor for non-suicide mortality in the elderly |
| Q47241607 | Depression in patients with high-grade glioma: results of the Glioma Outcomes Project |
| Q45720090 | Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients |
| Q34046222 | Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival |
| Q36745462 | Early treatment of depressive symptoms and long-term survival after liver transplantation |
| Q51901262 | Factors influencing change in health-related quality of life after liver transplantation. |
| Q92460457 | Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms |
| Q47785236 | Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients |
| Q51870832 | Importance of depression and active coping in liver transplant candidates' quality of life. |
| Q34499979 | Integration of palliative care in end-stage liver disease and liver transplantation |
| Q26866180 | Liver transplant-psychiatric and psychosocial aspects |
| Q51068514 | Longitudinal prospective measurement of the quality of life before and after liver transplantation among adults. |
| Q38843237 | MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective |
| Q38528791 | Neurocognitive status is associated with all-cause mortality among psychiatric, high-risk liver transplant candidates and recipients |
| Q38538154 | Organ transplant & the psychiatrist: An overview |
| Q37706741 | PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis |
| Q38412129 | Palliative care for patients with end-stage liver disease |
| Q47572557 | Prediction of end-of-life fears in COPD - hoping for the best but preparing for the worst |
| Q48490720 | Prolonged posttransplant survival with treatment of depressive symptoms |
| Q46491767 | Psychiatric differences between liver transplant candidates with familial amyloid polyneuropathy and those with alcoholic liver disease |
| Q51091379 | Quality of life and functional status of liver transplant recipients with recurrent viral hepatitis C. |
| Q38245124 | Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation |
| Q35095535 | Risk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based study |
| Q50646043 | Specific psychiatric morbidity in liver cirrhosis in a Nigerian general hospital setting. |
| Q57805078 | Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis |
| Q43636733 | The Impact of Iatrogenically Acquired Hepatitis C Infection on the Well-being and Relationships of a Group of Irish Women |
| Q52351014 | The assessment and management of pain in cirrhosis. |
| Q35251998 | The cognitive profile of depressed patients with cirrhosis |
| Q54976907 | The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. |
| Q38197145 | What is the patient experience in advanced liver disease? A scoping review of the literature |